CORPORATE GOVERNANCE & LEADERSHIP

GOVERNANCE CHARTERS AND DOCUMENTS

Merit Medical Systems, Inc. (Nasdaq: MMSI) is a worldwide designer, developer, manufacturer and marketer of medical devices used in interventional and diagnostic procedures.

MERIT BOARD OF DIRECTORS

A Scott Anderson - Merit Medical Board of DirectorsA. SCOTT ANDERSON

Lead Independent Director

Director Since: November 2011
Committees: Compensation (Chair); ESG
Other Public Boards: None
Education: B.A. (philosophy, economics), Columbia University; M.S. (economics, international studies), Johns Hopkins University

Career Highlights
– President and CEO of Zions First National Bank (commercial bank based in the intermountain U.S.), 1990 to present
– Member of Board of Trustees of Intermountain Healthcare (integrated healthcare system in Utah and Idaho), 2005 to present (Chair, 2012 to 2018)
– Director of the Federal Reserve Bank of San Francisco (Salt Lake City Branch), 2003 to 2008

Qualifications of Particular Relevance to Merit
Mr. Anderson contributes to the Board’s deliberations more than 40 years of experience in the banking and financial services industries. The Board believes Mr. Anderson provides insight regarding national and international financial and credit markets, as well as lending practices, which are valuable as we continue to implement our growth strategy. Mr. Anderson also contributes extensive business and corporate governance experience to the strategic planning and operational discussions of the Board. Mr. Anderson’s business and corporate governance experience have been instrumental in the deliberations of our Compensation Committee, which he chairs, and the development of our executive compensation practices.

Jill Anderson - Merit Medical Board of DirectorsJILL ANDERSON

Director

Director Since: January 2019
Committees: Finance
Other Public Boards: None
Education: B.A. (finance), Temple University; M.B.A., Temple University

Career Highlights
– President, Chief Executive Officer and Director of Cianna Medical from January 2008 until the Company’s acquisition of Cianna Medical in November 2018
– President of BioLucent, Inc. from May 2001 to September 2007
– Previously served on the Board of Directors for Mammoplan LLC, and Solis Women’s Health

Qualifications of Particular Relevance to Merit
Ms. Anderson is a healthcare executive with more than 18 years of experience leading the innovation, development and commercialization of medical devices. The Board believes she brings innovative thinking and creative problem solving to addressing complex business problems in the search for growth opportunities. Ms. Anderson is skilled in building executive-level teams, commercializing breakthrough technologies, strategic planning, market strategy, company and product branding, marketing and communications. Her entrepreneurial nature and commitment to patient care has contributed to the development and successful exit of two venture-backed medical device companies and the organization and operation of several for-profit and not-for-profit comprehensive cancer centers.

LONNY J. CARPENTER

Director

Director Since: June 2020
Committees: Compensation; Finance; Operating (Chair)
Other Public Boards: Novanta, Inc.
Education: B.S., United States Military Academy at West Point

Career Highlights
– Member of the Board of Directors of Novanta Inc., a manufacturer of precision photonic and motion control components and subsystems, 2018 to present
– Member of the Board of Directors of Orchid Orthopedics Solutions (a privately-owned orthopedic medical device outsourcing company), 2019 to present
– Member of the Board of Directors of The Boler Company, (a privately-owned auto part manufacturing company), 2019 to present
– Group President, Global Quality and Business Operations of Stryker Corporation (Stryker), 2016 to 2019
– Group President, Global Quality and Operations of Stryker, 2011 to 2016
– President, Instruments and Medical Division of Stryker, 2006 to 2008
– Captain in the U.S. Army and helicopter pilot having served in leadership roles for the 101st Airborne Division

Qualifications of Particular Relevance to Merit
The Board believes Mr. Carpenter’s broad business background in setting enterprise-wide direction, experience in quality, manufacturing, procurement and logistics strategies from his tenure at Stryker will provide the Board with practical, real-world knowledge and guidance and will strengthen the Company’s efficiency and cost-reduction initiatives.

DAVID K. FLOYD

Director

Director Since: June 2020
Committees: Audit; ESG; Operating
Other Public Boards: NN, Inc.
Education: B.S., Grace College

Career Highlights
– Member of the Board of Directors of NN, Inc., a manufacturer of high-precision metal and plastic components and assemblies
– Member of the Board of Directors of Health Outcomes Performance Company (a privately-owned company focused on transforming the patient care experience and improving the practice of medicine), 2020 to present
– Advisor to Bain & Company (a private global management consulting services firm), 2019 to present.
– Group President of Stryker, 2012 to 2019
– U.S. President and Worldwide President of Johnson & Johnson’s DePuy Orthopaedics, 2007 to 2011

Qualifications of Particular Relevance to Merit
Mr. Floyd possesses more than 30 years of experience as a leader in the life sciences industry, including serving as president and CEO of several leading medical technology companies. Additionally, the Board believes Mr. Floyd’s nearly 20 years of general management experience would provide the Board with expertise on a broad range of matters, including mergers and acquisitions, global business and operations and product commercialization.

Thomas Gunderson - Merit Medical Board of DirectorsTHOMAS J. GUNDERSON

Director

Director Since: May 2017
Committees: Finance (Chair); Audit
Other Public Boards: None
Education: B.A. (biology focus), Carleton College; M.S. (cell biology), University of Minnesota; M.B.A., University of St. Thomas

Career Highlights
– Chair of the Board of Directors of the Minneapolis Heart Institute Foundation, 2015 to present
– Executive in Residence at the University of Minnesota’s Medical Industry Leadership Institute, 2016 to present
– Member of American Heart Association Science and Technology Accelerator Committee, 2015 to 2017
– Managing Director and senior research analyst at Piper Jaffray (focus on medical technology companies), 1992 to 2016
– Project Director at American Medical Systems (private medical device company acquired by Pfizer in 1983), 1979 to 1992
– Recognized by several industry publications, including the Wall Street Journal, Institutional Investor, First Call, Thomson Reuters, and Medical Device and Diagnostic Industry (e.g., in 1996 and 2000, he was named an All-Star Analyst for medical stocks by the Wall Street Journal and in 2014, Thomson-Reuters named him “Top Stock Picker” in the medical technology sector)

Qualifications of Particular Relevance to Merit
Mr. Gunderson provides the Board with more than 25 years of substantive experience in the medical device industry, with a seasoned perspective on the challenges, trends and opportunities of publicly-traded medical device manufacturers, as well as a keen understanding of the Company’s competitive position within its industry. Mr. Gunderson also contributes a strong background in financial and economic analysis and valuable insights regarding business development and acquisition opportunities. Mr. Gunderson’s financial background and industry experience have been beneficial in his service as the Chair of our newly-established Finance Committee.

JAMES T. HOGAN

Director

Director Since: June 2020
Committees: Compensation; Operating
Other Public Boards: Prolung, Inc.
Education: B.A., University of Minnesota; MBA, University of Minnesota

Career Highlights
– Member of the Board of Directors of Prolung, Inc., a medical technology company specializing in predictive analytics technology, 2019 to present
– Member of the Board of Directors of Xenocor, Inc. (a privately-owned medical device company), 2019 to present
– President of Latin America at Medtronic Inc., now Medtronic plc, 2007 to 2016
– Director of Gastroenterology and Urology Division for Western Europe at Medtronic Inc., 2005 to 2007
– Director of Sales and Marketing for Europe, the Middle East and Africa at Pfizer Inc.’s American Medical Systems Division, 1991 to 1993

Qualifications of Particular Relevance to Merit
The Board believes Mr. Hogan’s extensive experience in sales, marketing and medical support activities in a large medical device company, combined with his international experience, having lived and worked in England, Switzerland, France, Israel and Holland will benefit the Company. Additionally, the Board believes Mr. Hogan’s background in medical device start-ups, having started three medical device companies in the cardiology, urology and vascular fields, all of which were purchased by larger medical device companies, will provide the Board with knowledge and experience with branding, innovating and dealing with ongoing challenges facing the medical device industry.

F Ann Millner - Merit Medical Board of DirectorsF. ANN MILLNER

Director

Director Since: July 2015
Committees: Audit; Compensation; ESG (Chair)
Other Public Boards: None
Education: B.S. (education), University of Tennessee; M.S. (allied health education and management), Southwest Texas State University; Ed.D (education administration), Brigham Young University; Completed medical technology program, Vanderbilt University

Career Highlights
– Regents Professor and Professor of Health Administrative Services at Weber State University, 2013 to present
– Member of the Utah State Senate (member of multiple committees and subcommittees), 2015 to present
– Member of Utah Governor’s Task Force on Educational Excellence, 2015 to present
– Member of Board of Trustees of Intermountain Healthcare (integrated healthcare system in Utah and Idaho), 2005 to present (serving as Vice Chair, 2017 to present)
– President of Weber State University, 2002 to 2012 (first female president of a Utah state university)
– Vice President of University Relations at Weber State University, 1993 to 2002
– Associate Dean of Continuing Education and Assistant Vice President of Community Partnerships at Weber State University, 1985 to 1993

Qualifications of Particular Relevance to Merit
The Board believes Dr. Millner’s qualifications to serve as a director of the Company include her executive leadership skills and her experience in the areas of organizational administration, operations and financial management, and business strategy. Those skills and experience have been particularly valuable to the Company in the course of Dr. Millner’s service as the Chair of our Governance Committee. During her service as the Chair of our Governance Committee, Dr. Millner has played a significant role in the development of our corporate governance practices and engagement with our shareholders.

Fred Lampropoulos - Board of Directors - Merit MedicalFRED LAMPROPOULOS

Founder, Chairman of the Board, CEO

Director Since: July 1987
Committees: Operating
Other Public Boards: None

Career Highlights
– Chair of the Board, CEO and President of the Company since its formation in 1987
– Chair of the Board and President of Utah Medical Products, Inc. (medical device manufacturer), 1983 to 1987
– Filed more than 200 domestic and international patents and applications on medical devices
– Serves on several community and advisory boards
– Recipient of numerous community and industry awards, including 2003 and 2018 Utah Governor’s Medal for Science and Technology

Qualifications of Particular Relevance to Merit
The Board believes the Company benefits immensely from Mr. Lampropoulos’ experience as founder, President and Chief Executive Officer. He plays an essential role in communicating the expectations, advice, concerns and encouragement of the Board to our employees. Mr. Lampropoulos has a deep knowledge and understanding of the Company, as well as the industry and markets in which our products compete. Mr. Lampropoulos also performs an essential function as the Chair of the Board, providing decisive leadership and direction to the activities and deliberations of the Board. The Board also believes Mr. Lampropoulos’ leadership, drive and determination are significant factors in our growth and development and continue to be tremendous assets to the Company and its shareholders.

Lynne Ward - Merit Medical Board of DirectorsLYNNE N. WARD

Director

Director Since: August 2019
Committees: Audit (Chair); ESG; Finance
Other Public Boards: None
Education: B.S. Accounting, University of Utah
Certified Public Accountant

Career Highlights
– Executive Director, my529 (formerly known as the Utah Educational Savings Plan), offering municipal fund securities, 2004 to 2019. Underlying investments were with Vanguard, Dimensional, PIMCO, Sallie Mae Bank and U.S. Bank.
– Member of the University of Utah’s Investment Advisory Committee, 2018 to present
– Member of the Board of Directors of the Blue Healthcare Bank, 2007 to 2009
– Member of the Board of Directors of Stampin’ Up!, 2010 to 2016
– Utah Chapter NACD Board of Directors, 2017 to present
– Walker Institute at Weber State University board of directors, 2012 to present
– Senior leader and advisor to Utah governors Olene S. Walker and Michael O. Leavitt
– Senior leader for Utah state government’s central accounting office and State Auditor’s Office

Qualifications of Particular Relevance to Merit
Ms. Ward demonstrated her diverse skills by creating and leading my529’s rapid growth of $950 million to $14 billion assets under management. The Board believes her high standards, strategic foresight and business development fueled the growth. Her cost management, and investment and marketing innovations of a highly regulated product led to year-over-year Gold ratings from Morningstar. The Board believes Ms. Ward has strong career experiences, including financial oversight capabilities and leadership of a rapidly growing organization. The Board believes her contributions will strengthen the Company’s strategic direction while encouraging operational excellence.

MERIT BOARD OF DIRECTORS

A. SCOTT ANDERSON

Lead Independent Director

A Scott Anderson - Merit Medical Board of DirectorsDirector Since: November 2011
Committees: Compensation (Chair); ESG
Other Public Boards: None
Education: B.A. (philosophy, economics), Columbia University; M.S. (economics, international studies), Johns Hopkins University

Career Highlights
– President and CEO of Zions First National Bank (commercial bank based in the intermountain U.S.), 1990 to present
– Member of Board of Trustees of Intermountain Healthcare (integrated healthcare system in Utah and Idaho), 2005 to present (Chair, 2012 to 2018)
– Director of the Federal Reserve Bank of San Francisco (Salt Lake City Branch), 2003 to 2008

Qualifications of Particular Relevance to Merit
Mr. Anderson contributes to the Board’s deliberations more than 40 years of experience in the banking and financial services industries. The Board believes Mr. Anderson provides insight regarding national and international financial and credit markets, as well as lending practices, which are valuable as we continue to implement our growth strategy. Mr. Anderson also contributes extensive business and corporate governance experience to the strategic planning and operational discussions of the Board. Mr. Anderson’s business and corporate governance experience have been instrumental in the deliberations of our Compensation Committee, which he chairs, and the development of our executive compensation practices.

JILL ANDERSON

Director

Jill Anderson - Merit Medical Board of DirectorsDirector Since: January 2019
Committees: Finance
Other Public Boards: None
Education: B.A. (finance), Temple University; M.B.A., Temple University

Career Highlights
– President, Chief Executive Officer and Director of Cianna Medical from January 2008 until the Company’s acquisition of Cianna Medical in November 2018
– President of BioLucent, Inc. from May 2001 to September 2007
– Previously served on the Board of Directors for Mammoplan LLC, and Solis Women’s Health

Qualifications of Particular Relevance to Merit
Ms. Anderson is a healthcare executive with more than 18 years of experience leading the innovation, development and commercialization of medical devices. The Board believes she brings innovative thinking and creative problem solving to addressing complex business problems in the search for growth opportunities. Ms. Anderson is skilled in building executive-level teams, commercializing breakthrough technologies, strategic planning, market strategy, company and product branding, marketing and communications. Her entrepreneurial nature and commitment to patient care has contributed to the development and successful exit of two venture-backed medical device companies and the organization and operation of several for-profit and not-for-profit comprehensive cancer centers.

LONNY J. CARPENTER

Director

Director Since: June 2020
Committees: Compensation; Finance; Operating (Chair)
Other Public Boards: Novanta, Inc.
Education: B.S., United States Military Academy at West Point

Career Highlights
– Member of the Board of Directors of Novanta Inc., a manufacturer of precision photonic and motion control components and subsystems, 2018 to present
– Member of the Board of Directors of Orchid Orthopedics Solutions (a privately-owned orthopedic medical device outsourcing company), 2019 to present
– Member of the Board of Directors of The Boler Company, (a privately-owned auto part manufacturing company), 2019 to present
– Group President, Global Quality and Business Operations of Stryker Corporation (Stryker), 2016 to 2019
– Group President, Global Quality and Operations of Stryker, 2011 to 2016
– President, Instruments and Medical Division of Stryker, 2006 to 2008
– Captain in the U.S. Army and helicopter pilot having served in leadership roles for the 101st Airborne Division

Qualifications of Particular Relevance to Merit
The Board believes Mr. Carpenter’s broad business background in setting enterprise-wide direction, experience in quality, manufacturing, procurement and logistics strategies from his tenure at Stryker will provide the Board with practical, real-world knowledge and guidance and will strengthen the Company’s efficiency and cost-reduction initiatives.

DAVID K. FLOYD

Director

Director Since: June 2020
Committees: Audit; ESG; Operating
Other Public Boards: NN, Inc.
Education: B.S., Grace College

Career Highlights
– Member of the Board of Directors of NN, Inc., a manufacturer of high-precision metal and plastic components and assemblies
– Member of the Board of Directors of Health Outcomes Performance Company (a privately-owned company focused on transforming the patient care experience and improving the practice of medicine), 2020 to present
– Advisor to Bain & Company (a private global management consulting services firm), 2019 to present.
– Group President of Stryker, 2012 to 2019
– U.S. President and Worldwide President of Johnson & Johnson’s DePuy Orthopaedics, 2007 to 2011

Qualifications of Particular Relevance to Merit
Mr. Floyd possesses more than 30 years of experience as a leader in the life sciences industry, including serving as president and CEO of several leading medical technology companies. Additionally, the Board believes Mr. Floyd’s nearly 20 years of general management experience would provide the Board with expertise on a broad range of matters, including mergers and acquisitions, global business and operations and product commercialization.

THOMAS J. GUNDERSON

Director

Thomas Gunderson - Merit Medical Board of DirectorsDirector Since: May 2017
Committees: Audit; Finance (Chair)
Other Public Boards: None
Education: B.A. (biology focus), Carleton College; M.S. (cell biology), University of Minnesota; M.B.A., University of St. Thomas

Career Highlights
– Chair of the Board of Directors of the Minneapolis Heart Institute Foundation, 2015 to present
– Executive in Residence at the University of Minnesota’s Medical Industry Leadership Institute, 2016 to present
– Member of American Heart Association Science and Technology Accelerator Committee, 2015 to 2017
– Managing Director and senior research analyst at Piper Jaffray (focus on medical technology companies), 1992 to 2016
– Project Director at American Medical Systems (private medical device company acquired by Pfizer in 1983), 1979 to 1992
– Recognized by several industry publications, including the Wall Street Journal, Institutional Investor, First Call, Thomson Reuters, and Medical Device and Diagnostic Industry (e.g., in 1996 and 2000, he was named an All-Star Analyst for medical stocks by the Wall Street Journal and in 2014, Thomson-Reuters named him “Top Stock Picker” in the medical technology sector)

Qualifications of Particular Relevance to Merit
Mr. Gunderson provides the Board with more than 25 years of substantive experience in the medical device industry, with a seasoned perspective on the challenges, trends and opportunities of publicly-traded medical device manufacturers, as well as a keen understanding of the Company’s competitive position within its industry. Mr. Gunderson also contributes a strong background in financial and economic analysis and valuable insights regarding business development and acquisition opportunities. Mr. Gunderson’s financial background and industry experience have been beneficial in his service as the Chair of our newly-established Finance Committee.

JAMES T. HOGAN

Director

James T. Hogan - Merit Medical Board of DirectorsDirector Since: June 2020
Committees: Compensation; Operating
Other Public Boards:Prolung, Inc.
Education: B.A., University of Minnesota; MBA, University of Minnesota

Career Highlights
– Member of the Board of Directors of Prolung, Inc., a medical technology company specializing in predictive analytics technology, 2019 to present
– Member of the Board of Directors of Xenocor, Inc. (a privately-owned medical device company), 2019 to present
– President of Latin America at Medtronic Inc., now Medtronic plc, 2007 to 2016
– Director of Gastroenterology and Urology Division for Western Europe at Medtronic Inc., 2005 to 2007
– Director of Sales and Marketing for Europe, the Middle East and Africa at Pfizer Inc.’s American Medical Systems Division, 1991 to 1993

Qualifications of Particular Relevance to Merit
The Board believes Mr. Hogan’s extensive experience in sales, marketing and medical support activities in a large medical device company, combined with his international experience, having lived and worked in England, Switzerland, France, Israel and Holland will benefit the Company. Additionally, the Board believes Mr. Hogan’s background in medical device start-ups, having started three medical device companies in the cardiology, urology and vascular fields, all of which were purchased by larger medical device companies, will provide the Board with knowledge and experience with branding, innovating and dealing with ongoing challenges facing the medical device industry.

FRED LAMPROPOULOS

Founder, Chairman of the Board, CEO

Fred Lampropoulos - Board of Directors - Merit MedicalDirector Since: July 1987
Committees: Operating
Other Public Boards: None

Career Highlights
– Chair of the Board, CEO and President of the Company since its formation in 1987
– Chair of the Board and President of Utah Medical Products, Inc. (medical device manufacturer), 1983 to 1987
– Filed more than 200 domestic and international patents and applications on medical devices
– Serves on several community and advisory boards
– Recipient of numerous community and industry awards, including 2003 and 2018 Utah Governor’s Medal for Science and Technology

Qualifications of Particular Relevance to Merit
The Board believes the Company benefits immensely from Mr. Lampropoulos’ experience as founder, President and Chief Executive Officer. He plays an essential role in communicating the expectations, advice, concerns and encouragement of the Board to our employees. Mr. Lampropoulos has a deep knowledge and understanding of the Company, as well as the industry and markets in which our products compete. Mr. Lampropoulos also performs an essential function as the Chair of the Board, providing decisive leadership and direction to the activities and deliberations of the Board. The Board also believes Mr. Lampropoulos’ leadership, drive and determination are significant factors in our growth and development and continue to be tremendous assets to the Company and its shareholders.

F. ANN MILLNER

Director

F Ann Millner - Merit Medical Board of DirectorsDirector Since: July 2015
Committees: Audit; Compensation; ESG (Chair)
Other Public Boards: None
Education: B.S. (education), University of Tennessee; M.S. (allied health education and management), Southwest Texas State University; Ed.D (education administration), Brigham Young University; Completed medical technology program, Vanderbilt University

Career Highlights
– Regents Professor and Professor of Health Administrative Services at Weber State University, 2013 to present
– Member of the Utah State Senate (member of multiple committees and subcommittees), 2015 to present
– Member of Utah Governor’s Task Force on Educational Excellence, 2015 to present
– Member of Board of Trustees of Intermountain Healthcare (integrated healthcare system in Utah and Idaho), 2005 to present (serving as Vice Chair, 2017 to present)
– President of Weber State University, 2002 to 2012 (first female president of a Utah state university)
– Vice President of University Relations at Weber State University, 1993 to 2002
– Associate Dean of Continuing Education and Assistant Vice President of Community Partnerships at Weber State University, 1985 to 1993

Qualifications of Particular Relevance to Merit
The Board believes Dr. Millner’s qualifications to serve as a director of the Company include her executive leadership skills and her experience in the areas of organizational administration, operations and financial management, and business strategy. Those skills and experience have been particularly valuable to the Company in the course of Dr. Millner’s service as the Chair of our Governance Committee. During her service as the Chair of our Governance Committee, Dr. Millner has played a significant role in the development of our corporate governance practices and engagement with our shareholders.

LYNNE N. WARD

Director

Lynne N. Ward - Merit Medical Board of DirectorsDirector Since: August 2019
Committees: Audit (Chair); ESG; Finance
Other Public Boards: None
Education: B.S. Accounting, University of Utah
Certified Public Accountant

Career Highlights
– Executive Director, my529 (formerly known as the Utah Educational Savings Plan), offering municipal fund securities, 2004 to 2019. Underlying investments were with Vanguard, Dimensional, PIMCO, Sallie Mae Bank and U.S. Bank.
– Member of the University of Utah’s Investment Advisory Committee, 2018 to present
– Member of the Board of Directors of the Blue Healthcare Bank, 2007 to 2009
– Member of the Board of Directors of Stampin’ Up!, 2010 to 2016
– Utah Chapter NACD Board of Directors, 2017 to present
– Walker Institute at Weber State University board of directors, 2012 to present
– Senior leader and advisor to Utah governors Olene S. Walker and Michael O. Leavitt
– Senior leader for Utah state government’s central accounting office and State Auditor’s Office

Qualifications of Particular Relevance to Merit
Ward was the Executive Director of my529 (formerly Utah Educational Savings Plan), the nation’s largest state-run college savings plan offering municipal fund securities. Under her leadership, my529’s assets under management have grown from approximately $950 million in approximately 48,000 accounts to approximately $14 billion in approximately 400,000 accounts. At my529, a consistently top-rated plan, Ward established the organization’s growth strategy. She oversaw execution of investment offerings, IT development, federal and state legislative affairs, cybersecurity, audits, customer service and marketing. Ward, a Certified Public Accountant, served as a senior leader and advisor to Utah governors Olene S. Walker and Michael O. Leavitt. She has extensive for-profit and non-profit board experience which includes Stampin’ Up! Inc., Blue Healthcare Bank, the University of Utah Investment Advisory Committee and the Utah Chapter National Association of Corporate Directors.

COMMITTEES AND MEMBERS

Here is a summary of our Board of Director’s committee structure and membership information. To read more about any of the committees, click on committee names below.

Lynne N. Ward — Chair
David K. Floyd
Thomas J. Gunderson
F. Ann Millner, Ed.D.

A. Scott Anderson — Chair
Lonny J. Carpenter
James T. Hogan
F. Ann Millner, Ed.D.

F. Ann Millner, Ed.D. – Chair
A. Scott Anderson
David K. Floyd
Lynne N. Ward

Thomas J. Gunderson – Chair
Jill D. Anderson
Lonny J. Carpenter
Lynne N. Ward

Lonny J. Carpenter – Chair
David K. Floyd
James T. Hogan
Fred P. Lampropoulos

Nolan Karas - Merit Medical Board of DirectorsNOLAN E. KARRAS

Lead Independent Director

Director Since: November 2011
Committees: Audit (Chair); Finance
Other Public Boards: PacifiCorp, Scottish Power
Education: B.A., Weber State University; M.B.A., University of Utah;
Certified Public Accountant

Career Highlights
– Chair and CEO of The Karras Company, Inc. (investment advisory firm), 1997 to present
– Chair and Member of Board of Trustees of Weber State University (chair of audit committee), 2013 to present
– Chair of Utah Governor’s Education Excellence Commission, 2015 to 2018
– Community Board of Directors of University of Utah Hospitals and Clinics (chair of finance committee), 2009 to 2014
– CEO of Western Hay Company, Inc. (agricultural products company), 1995 to 2012, and director, 1995 to 2018)
– Board of Directors of Beneficial Life Insurance Company (privately-held life insurance company) (chair of finance committee and member of executive committee), 1996 to 2009
– Member of the Utah State Board of Regents, 2001 to 2013 (chair, 2002 to 2006)
– Former director and member of audit and compensation committees of boards of directors of PacifiCorp (a public utility operating in the northwestern United States) and Scottish Power (multinational energy company)
– Several positions in public service, including ten years as Speaker of the House and House Majority Leader of the Utah House of Representatives

Qualifications of Particular Relevance to Merit
Mr. Karras’ experience and skills qualify him to work constructively with our management and directors, especially in connection with our pursuit of growth and expansion opportunities. The Board believes Mr. Karras’ financial acumen and experience in corporate governance are valuable to its deliberations and strategic planning and in his service as Chair of the Audit Committee. Mr. Karras also has a keen awareness of the social, political and economic environments in which the Company’s principal facilities are located.

NOLAN E. KARRAS

Lead Independent Director

Nolan Karas - Merit Medical Board of DirectorsDirector Since: November 2011
Committees: Audit (Chair); Finance
Other Public Boards: PacifiCorp, Scottish Power
Education: B.A., Weber State University; M.B.A., University of Utah;
Certified Public Accountant

Career Highlights
– Chair and CEO of The Karras Company, Inc. (investment advisory firm), 1997 to present
– Chair and Member of Board of Trustees of Weber State University (chair of audit committee), 2013 to present
– Chair of Utah Governor’s Education Excellence Commission, 2015 to 2018
– Community Board of Directors of University of Utah Hospitals and Clinics (chair of finance committee), 2009 to 2014
– CEO of Western Hay Company, Inc. (agricultural products company), 1995 to 2012, and director, 1995 to 2018)
– Board of Directors of Beneficial Life Insurance Company (privately-held life insurance company) (chair of finance committee and member of executive committee), 1996 to 2009
– Member of the Utah State Board of Regents, 2001 to 2013 (chair, 2002 to 2006)
– Former director and member of audit and compensation committees of boards of directors of PacifiCorp (a public utility operating in the northwestern United States) and Scottish Power (multinational energy company)
– Several positions in public service, including ten years as Speaker of the House and House Majority Leader of the Utah House of Representatives

Qualifications of Particular Relevance to Merit
Mr. Karras’ experience and skills qualify him to work constructively with our management and directors, especially in connection with our pursuit of growth and expansion opportunities. The Board believes Mr. Karras’ financial acumen and experience in corporate governance are valuable to its deliberations and strategic planning and in his service as Chair of the Audit Committee. Mr. Karras also has a keen awareness of the social, political and economic environments in which the Company’s principal facilities are located.

Kent Stanger - Merit Medical Board of DirectorsKENT STANGER

Director

Director Since: September 1987
Committees: Finance
Other Public Boards: None
Education: B.A. (accounting), Weber State University
Former Certified Public Accountant

Career Highlights
– Member of Board of Directors and Executive Committee of Utah Taxpayers Association, 2012 to 2016
– Chief Financial Officer, Secretary and Treasurer of the Company, 1987 to 2015
– Controller of Utah Medical Products, Inc. (medical device manufacturer), 1985 to 1987
– Corporate Controller for Laser Corporation, American Laser and Modulaire Industries, Inc., 1982 to 1985
– Hansen, Barnett and Maxwell (former Utah accounting firm that merged with Eide Bailly LLP in 2013) as practicing certified public accountant, 1979 to 1982

Qualifications of Particular Relevance to Merit
Mr. Stanger was a founder of the Company and, through more than 27 years of service as the principal financial manager of the Company, developed a broad understanding of our business and operations, as well as the industry and markets in which the Company competes. The Board values Mr. Stanger’s accounting and financial management skills and benefits greatly from his extensive knowledge of our history, achievements, competitive position and strategic objectives.

KENT STANGER

Director

Kent Stanger - Merit Medical Board of DirectorsDirector Since: September 1987
Committees: Finance
Other Public Boards: None
Education: B.A. (accounting), Weber State University
Former Certified Public Accountant

Career Highlights
– Member of Board of Directors and Executive Committee of Utah Taxpayers Association, 2012 to 2016
– Chief Financial Officer, Secretary and Treasurer of the Company, 1987 to 2015
– Controller of Utah Medical Products, Inc. (medical device manufacturer), 1985 to 1987
– Corporate Controller for Laser Corporation, American Laser and Modulaire Industries, Inc., 1982 to 1985
– Hansen, Barnett and Maxwell (former Utah accounting firm that merged with Eide Bailly LLP in 2013) as practicing certified public accountant, 1979 to 1982

Qualifications of Particular Relevance to Merit
Mr. Stanger was a founder of the Company and, through more than 27 years of service as the principal financial manager of the Company, developed a broad understanding of our business and operations, as well as the industry and markets in which the Company competes. The Board values Mr. Stanger’s accounting and financial management skills and benefits greatly from his extensive knowledge of our history, achievements, competitive position and strategic objectives.

Dr David Liu - Merit Medical Board of DirectorsDAVID M. LIU, M.D.

Director

Director Since: July 2016
Committees: ESG; Finance
Other Public Boards: None
Education: M.D., University of Toronto; Radiology residency at University of British Columbia;
Interventional radiology fellowship at Northwestern Memorial Hospital

Career Highlights
– Interventional radiologist (certified in the U.S. and Canada), practicing at the Vancouver General Hospital, University of British Columbia Hospital, and BC Cancer Agency (with cross appointment in surgery department), 2008 to present
– Clinical Associate Professor of Radiology at the University of British Columbia, 2008 to present
– Medical Director at Eva Vein Care (team of physicians specializing in diagnostic assessment, endovascular therapy and interventional radiology), 2012 to present
– Co-founder and co-chair of the symposium on Hepatic Oncology at Whistler, an international liver cancer symposium
– Credited with 7 book chapters, over 60 publications, and 100 invited lectures around the world
– Inducted Fellow of the Society of Interventional Radiology

Qualifications of Particular Relevance to Merit
In addition to benchside and clinical research in the fields of novel embolic platforms, ablative technologies and cancer-related thromboembolic disease, Dr. Liu maintains an interventional oncology practice incorporating multiple aspects of embolization, ablation, venous access and palliative therapy in organ systems. Fluent in Mandarin, Dr. Liu is an active member of the interventional radiology community and has served as an advisor on multiple global advisory boards and technology development committees for various scientific and commercial organizations. The Board believes Dr. Liu’s extensive industry experience, scientific credentials and active clinical practice provide him with vital insights into the trends, risks and opportunities in many of our core interests. Dr. Liu also contributes valuable clinical and industry perspective to the Board’s analysis of prospective acquisitions, product development and other strategic decisions.

DAVID M. LIU, M.D.

Director

Dr David Liu - Merit Medical Board of DirectorsDirector Since: July 2016
Committees: ESG; Finance
Other Public Boards: None
Education: M.D., University of Toronto; Radiology residency at University of British Columbia;
Interventional radiology fellowship at Northwestern Memorial Hospital

Career Highlights
– Interventional radiologist (certified in the U.S. and Canada), practicing at the Vancouver General Hospital, University of British Columbia Hospital, and BC Cancer Agency (with cross appointment in surgery department), 2008 to present
– Clinical Associate Professor of Radiology at the University of British Columbia, 2008 to present
– Medical Director at Eva Vein Care (team of physicians specializing in diagnostic assessment, endovascular therapy and interventional radiology), 2012 to present
– Co-founder and co-chair of the symposium on Hepatic Oncology at Whistler, an international liver cancer symposium
– Credited with 7 book chapters, over 60 publications, and 100 invited lectures around the world
– Inducted Fellow of the Society of Interventional Radiology

Qualifications of Particular Relevance to Merit
In addition to benchside and clinical research in the fields of novel embolic platforms, ablative technologies and cancer-related thromboembolic disease, Dr. Liu maintains an interventional oncology practice incorporating multiple aspects of embolization, ablation, venous access and palliative therapy in organ systems. Fluent in Mandarin, Dr. Liu is an active member of the interventional radiology community and has served as an advisor on multiple global advisory boards and technology development committees for various scientific and commercial organizations. The Board believes Dr. Liu’s extensive industry experience, scientific credentials and active clinical practice provide him with vital insights into the trends, risks and opportunities in many of our core interests. Dr. Liu also contributes valuable clinical and industry perspective to the Board’s analysis of prospective acquisitions, product development and other strategic decisions.

Franklin Miller - Merit Medical Board of DirectorsFRANKLIN J. MILLER, M.D.

Director

Director Since: May 2005
Committees: ESG, Compensation
Other Public Boards: None
Education: B.S. (pre-med), Pennsylvania State University; M.D., Temple University Medical School; Residency and fellowship, Johns Hopkins University

Career Highlights
– Consultant to the Company, assisting in product testing and development, 1997 to 2005
– Professor of Radiology and Surgery at the University of Utah Department of Radiology, 1976 to 2005 (Director of Interventional Radiology, 1976 to 2001)
– Clinical Professor of Radiology at the University of California, San Diego (began the Hereditary Hemorrhagic Telangiectasia Clinic, one of only eight such clinics in the United States), 2002 to 2011
– Served on advisory boards to several medical device companies and member of editorial and review boards for numerous medical journals

Qualifications of Particular Relevance to Merit
Dr. Miller contributes a valuable set of skills, training and experience to the Board’s deliberations. During his service as a director, Dr. Miller has provided significant advice regarding our product development strategy and plays a significant role in our evaluation of acquisition and other growth opportunities. Based, in part, on his extensive medical training and his experience with various medical devices, Dr. Miller provides the Board valuable insight regarding the needs and preferences of the medical professionals who use and purchase our products.

FRANKLIN J. MILLER, M.D.

Director

Franklin Miller - Merit Medical Board of DirectorsDirector Since: May 2005
Committees: ESG, Compensation
Other Public Boards: None
Education: B.S. (pre-med), Pennsylvania State University; M.D., Temple University Medical School; Residency and fellowship, Johns Hopkins University

Career Highlights
– Consultant to the Company, assisting in product testing and development, 1997 to 2005
– Professor of Radiology and Surgery at the University of Utah Department of Radiology, 1976 to 2005 (Director of Interventional Radiology, 1976 to 2001)
– Clinical Professor of Radiology at the University of California, San Diego (began the Hereditary Hemorrhagic Telangiectasia Clinic, one of only eight such clinics in the United States), 2002 to 2011
– Served on advisory boards to several medical device companies and member of editorial and review boards for numerous medical journals

Qualifications of Particular Relevance to Merit
Dr. Miller contributes a valuable set of skills, training and experience to the Board’s deliberations. During his service as a director, Dr. Miller has provided significant advice regarding our product development strategy and plays a significant role in our evaluation of acquisition and other growth opportunities. Based, in part, on his extensive medical training and his experience with various medical devices, Dr. Miller provides the Board valuable insight regarding the needs and preferences of the medical professionals who use and purchase our products.

Merit Medical
logo

Part

Page

Video

Post

X